Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

112.61 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
2 Hypergrowth Stocks That Are Screaming Buys in November
Via The Motley Fool
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
 
Via Benzinga
Looking Into TransMedics Gr's Recent Short Interest
 
Via Benzinga
Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
Amphenol (APH) is a terrific stock, reporting better-than-expected earnings, while Cramer prefers CTRA over DVN and doesn't see potential in TMDX. 
Via Benzinga
Navigating 11 Analyst Ratings For TransMedics Gr
 
Via Benzinga
Is TransMedics Group Stock a Buy?
This organ transplant specialist is down, but still has plenty of signs of life. 
Via The Motley Fool
This Is What Whales Are Betting On TransMedics Gr
 
Via Benzinga
Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,000 Today
 
Via Benzinga
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of delivery services for transplant organs. 
Via The Motley Fool
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Why TransMedics Stock Plunged in October
The organ transplant specialist posted disappointing results in its third-quarter report. 
Via The Motley Fool
1 Top Growth Stock Down 50% to Buy After Its Recent Pullback
TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity. 
Via The Motley Fool
3 Stocks Well Below 52-Week Highs With Strong Growth Projections
These three stocks are trading deeply below their 52-week highs, and analyst project them to see big increases in earnings and revenue over coming years. 
Via MarketBeat
Topics Immigration
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
The major indexes declined, but haven't fallen apart. 
Via Investor's Business Daily
TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
 
Via Benzinga
Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries
TransMedics Group shares fall as Q3 EPS misses estimates; revenue rises 64% but falls short of consensus. Analysts cut price targets, citing weaker transplant volumes. 
Via Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results
 
Via Benzinga
TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat?
Is this the buy-the-dip opportunity investors have been waiting for? 
Via The Motley Fool
TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm
From DiCello Levitt LLP
Via GlobeNewswire
TransMedics, F5 Lead Big After-Hours Earnings Winners, Losers
With earnings season in full swing, big movers abound. 
Via Investor's Business Daily
TransMedics Group Stock Sinks On Q3 Earnings: The Details
TransMedics Group shares are trading lower in Monday's after-hours session after the company reported worse-than-expected financial results for the third quarter. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.